Dying for attention: microparticles and angiogenesis.

See article by Brill et al. [18] (pages 30–38) in this issue. Microparticles, which were initially described as cell dust, have revealed over the past few years several exciting and unexpected properties. Microparticles are submicron vesicles shed from plasma membranes following cell activation or apoptosis, whose protein and lipid profile may be considered as a snapshot of the phenotype of the cell they stem from. The molecular mechanisms of microparticle formation and shedding are not yet fully understood, but seem to involve the changes in the cytoskeleton and exposure of phosphatidylserine on the outer leaflet of the plasma membrane [1,2]. Nevertheless, microparticles can easily be generated in vitro from aggregating platelets or from cultured cells following activation or apoptosis. Microparticles are also found circulating in the blood. Their numbers increase in patients exhibiting hypercoagulability and decrease in those with bleeding disorders [2,3]. Presence of microparticles has also been documented at sites of inflammation such as the acellular lipid core of the atherosclerotic plaque or the synovial fluid from patients with rheumatoid arthritis [3–6]. Furthermore, increased numbers … *Corresponding author. Tel.: +33 1 4463 1864; fax: +33 1 4281 3128. Email address: chantal.boulanger{at}larib.inserm.fr

[1]  P. Carmeliet,et al.  Regulation of angiogenesis by tissue factor cytoplasmic domain signaling , 2004, Nature Medicine.

[2]  ZiadMallat,et al.  Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes , 2000 .

[3]  J. Freyssinet,et al.  More on: measuring circulating cell‐derived microparticles , 2005, Journal of thrombosis and haemostasis : JTH.

[4]  A. Tedgui,et al.  Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction , 2001, Circulation.

[5]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .

[6]  J. Freyssinet Cellular microparticles: what are they bad or good for? , 2003, Journal of thrombosis and haemostasis : JTH.

[7]  E. Fisher,et al.  Release of active tissue factor by human arterial smooth muscle cells. , 2000, Circulation research.

[8]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[9]  H. Kleinman,et al.  Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. , 2002, Cancer research.

[10]  A. Schroit,et al.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.

[11]  I. Maruyama,et al.  Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region , 2003, Journal of thrombosis and haemostasis : JTH.

[12]  G. FitzGerald,et al.  Arachidonic Acid in Platelet Microparticles Up-regulates Cyclooxygenase-2-dependent Prostaglandin Formation via a Protein Kinase C/Mitogen-activated Protein Kinase-dependent Pathway* , 1999, The Journal of Biological Chemistry.

[13]  C. Hack,et al.  Human cell‐derived microparticles promote thrombus formation in vivo in a tissue factor‐dependent manner , 2003, Journal of thrombosis and haemostasis : JTH.

[14]  G. FitzGerald,et al.  Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.

[15]  F. Breedveld,et al.  Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. , 2002, Arthritis and rheumatism.

[16]  Vincenza Dolo,et al.  Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. , 2002, The American journal of pathology.

[17]  J. Badimón,et al.  Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Nieuwland,et al.  Measuring circulating cell‐derived microparticles , 2004, Journal of thrombosis and haemostasis : JTH.

[19]  A. Tedgui,et al.  Current perspective on the role of apoptosis in atherothrombotic disease. , 2001, Circulation research.

[20]  H. K. Kim,et al.  Platelet microparticles induce angiogenesis in vitro , 2004, British journal of haematology.

[21]  R. Nieuwland,et al.  Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.

[22]  D. Wagner,et al.  New links between inflammation and thrombosis. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[23]  M. Goligorsky,et al.  Endothelium-derived microparticles impair endothelial function in vitro. , 2004, American journal of physiology. Heart and circulatory physiology.

[24]  A. Brill,et al.  Differential role of platelet granular mediators in angiogenesis. , 2004, Cardiovascular research.

[25]  J. Freyssinet,et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.